NASDAQ:ALDX - Aldeyra Therapeutics SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$7.30 -0.06 (-0.82 %)
(As of 05/19/2019 08:58 AM ET)
Previous Close$7.30
Today's Range$7.24 - $7.47
52-Week Range$6.75 - $16.70
Volume136,153 shs
Average Volume179,193 shs
Market Capitalization$200.68 million
P/E RatioN/A
Dividend YieldN/A
Beta0.71

SEC Filings

Aldeyra Therapeutics (NASDAQ:ALDX) SEC Filings

DateFilerForm TypeView
05/10/2019
3:11 PM
Aldeyra Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/09/2019
6:09 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/22/2019
3:10 PM
Aldeyra Therapeutics (Filer)
Form DEFA14A
View Filing
04/22/2019
3:05 PM
Aldeyra Therapeutics (Filer)
Form DEF 14A
View Filing
03/28/2019
4:10 PM
Aldeyra Therapeutics (Issuer)
TREU JESSE I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/26/2019
6:53 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/08/2019
3:06 PM
Aldeyra Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/08/2019
6:15 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/07/2019
4:30 PM
Aldeyra Therapeutics (Issuer)
McMullin David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/07/2019
4:24 PM
Aldeyra Therapeutics (Issuer)
Reed Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/07/2019
4:22 PM
Aldeyra Therapeutics (Issuer)
Clark David J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/07/2019
4:20 PM
Aldeyra Therapeutics (Issuer)
Brady Todd C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/28/2019
6:21 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/14/2019
10:43 AM
683 Capital Management, LLC (Filed by)
Aldeyra Therapeutics (Subject)
Form SC 13G/A
View Filing
02/13/2019
3:53 PM
Aldeyra Therapeutics (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Form SC 13G/A
View Filing
02/11/2019
4:14 PM
Aldeyra Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
View Filing
01/29/2019
7:16 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/22/2019
10:28 AM
Aldeyra Therapeutics (Subject)
JOHNSON & JOHNSON (Filed by)
Form SC 13G/A
View Filing
12/28/2018
3:19 PM
Aldeyra Therapeutics (Filer)
Form 424B5
View Filing
12/28/2018
3:08 PM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/21/2018
7:11 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/14/2018
4:18 PM
Aldeyra Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/14/2018
6:46 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/04/2018
2:08 PM
Aldeyra Therapeutics (Filer)
Form CT ORDER
View Filing
09/28/2018
3:50 PM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/28/2018
3:34 PM
Aldeyra Therapeutics (Filer)
Form 424B5
View Filing
09/26/2018
3:15 PM
Aldeyra Therapeutics (Filer)
Form 424B5
View Filing
09/26/2018
6:47 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/25/2018
7:17 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/09/2018
3:17 PM
Aldeyra Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/09/2018
6:38 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/01/2018
3:46 PM
Aldeyra Therapeutics (Issuer)
Reed Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/01/2018
3:24 PM
Aldeyra Therapeutics (Issuer)
Reed Joshua (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
08/01/2018
3:17 PM
Aldeyra Therapeutics (Issuer)
McMullin David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
07/31/2018
7:13 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/29/2018
11:15 PM
Aldeyra Therapeutics (Filer)
Form EFFECT
View Filing
07/20/2018
3:26 PM
Aldeyra Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
View Filing
06/26/2018
7:13 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/11/2018
3:15 PM
Aldeyra Therapeutics (Issuer)
TREU JESSE I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
3:38 PM
Aldeyra Therapeutics (Issuer)
Bronstein Ben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
3:37 PM
Aldeyra Therapeutics (Issuer)
DOUGLAS RICHARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
3:36 PM
Aldeyra Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
3:35 PM
Aldeyra Therapeutics (Issuer)
Phillips Gary M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
3:35 PM
Aldeyra Therapeutics (Issuer)
JOYCE MARTIN JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
3:31 PM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/15/2018
6:37 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/25/2018
4:25 PM
Aldeyra Therapeutics (Filer)
Form DEFA14A
View Filing
04/25/2018
4:21 PM
Aldeyra Therapeutics (Filer)
Form DEF 14A
View Filing
03/29/2018
3:50 PM
Aldeyra Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
03/29/2018
3:44 PM
Aldeyra Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/29/2018
6:39 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/27/2018
7:14 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/13/2018
11:38 AM
Aldeyra Therapeutics (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Form SC 13G/A
View Filing
01/22/2018
3:10 PM
683 Capital Management, LLC (Filed by)
Aldeyra Therapeutics (Subject)
Form SC 13G
View Filing
12/01/2017
3:33 PM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
This page was last updated on 5/19/2019 by MarketBeat.com Staff

Featured Article: What are municipal bonds?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel